APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Single Nucleotide Polymorphism (SNP) Genotyping

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Selected research

Market Structure

Global Single Nucleotide Polymorphism (SNP) Genotyping Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174241350321 December 2025192 pages

Choose your research edition.

Industry ResearchSingle Nucleotide Polymorphism (SNP) Genotyping Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Single Nucleotide Polymorphism (SNP) Genotyping Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Single Nucleotide Polymorphism (SNP) Genotyping Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Single Nucleotide Polymorphism (SNP) Genotyping Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Global Single Nucleotide Polymorphism (SNP) Genotyping key players include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, etc. Global top five players hold a share about 65%.

North America is the largest market, with a share about 40%, followed by Europe and Japan, having a total share about 35 percent.

Read the full market overview

In terms of product, the segment includes Transversion, Transition. And in terms of application, the largest application is Diagnostics, followed by Animal, Plant, Research, etc.

Report Includes

This report provides an overview of the global Single Nucleotide Polymorphism (SNP) Genotyping market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Single Nucleotide Polymorphism (SNP) Genotyping and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Single Nucleotide Polymorphism (SNP) Genotyping revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Single Nucleotide Polymorphism (SNP) Genotyping market size, projected growth trends, production technologies, key applications, and end-use industries.

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Company

Illumina

Affymetrix

Applied Biosystems

Agilent Technologies

Beckman Coulter

Roche

Qiagen

Luminex Corporation

Enzo Life Sciences

Bio-rad

Sequenom

Ocimum Biosolutions

GE Healthcare

GenScript

Douglas Scientific

BGI

Beijing Sunbiotech

HuaGene Biotech

Generay Biotech

Benegene

Shanghai Biochip

GENESKY

HD Biosciences

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Type

Transversion

Transition

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Application

Diagnostics

Animal

Plant

Research

Others

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single Nucleotide Polymorphism (SNP) Genotyping market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Single Nucleotide Polymorphism (SNP) Genotyping and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single Nucleotide Polymorphism (SNP) Genotyping.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Single Nucleotide Polymorphism (SNP) Genotyping in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Single Nucleotide Polymorphism (SNP) Genotyping industry.

Chapter 3: Detailed analysis of Single Nucleotide Polymorphism (SNP) Genotyping companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Single Nucleotide Polymorphism (SNP) Genotypingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Transversion Table 3. Key Players of Transition Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Diagnostics Table 6. Key Players of Animal Table 7. Key Players of Plant Table 8. Key Players of Research Table 9. Key Players of Others Table 10. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2021-2026) Table 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2027-2032) Table 15. Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends Table 16. Single Nucleotide Polymorphism (SNP) Genotyping Industry Drivers Table 17. Single Nucleotide Polymorphism (SNP) Genotyping Industry Opportunities and Challenges Table 18. Single Nucleotide Polymorphism (SNP) Genotyping Industry Restraints Table 19. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Company (2021-2026) Table 21. Global Single Nucleotide Polymorphism (SNP) Genotyping Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Single Nucleotide Polymorphism (SNP) Genotyping Key Company Head Office and Area Served Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Company, Product Type & Application Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Single Nucleotide Polymorphism (SNP) Genotyping by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2021-2026) Table 31. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2027-2032) Table 32. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2021-2026) Table 36. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2027-2032) Table 37. Illumina Company Information Table 38. Illumina Business Overview Table 39. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 41. Illumina Recent Development Table 42. Affymetrix Company Information Table 43. Affymetrix Business Overview Table 44. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 46. Affymetrix Recent Development Table 47. Applied Biosystems Company Information Table 48. Applied Biosystems Business Overview Table 49. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 51. Applied Biosystems Recent Development Table 52. Agilent Technologies Company Information Table 53. Agilent Technologies Business Overview Table 54. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 56. Agilent Technologies Recent Development Table 57. Beckman Coulter Company Information Table 58. Beckman Coulter Business Overview Table 59. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 61. Beckman Coulter Recent Development Table 62. Roche Company Information Table 63. Roche Business Overview Table 64. Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 66. Roche Recent Development Table 67. Qiagen Company Information Table 68. Qiagen Business Overview Table 69. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 71. Qiagen Recent Development Table 72. Luminex Corporation Company Information Table 73. Luminex Corporation Business Overview Table 74. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 76. Luminex Corporation Recent Development Table 77. Enzo Life Sciences Company Information Table 78. Enzo Life Sciences Business Overview Table 79. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 81. Enzo Life Sciences Recent Development Table 82. Bio-rad Company Information Table 83. Bio-rad Business Overview Table 84. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 86. Bio-rad Recent Development Table 87. Sequenom Company Information Table 88. Sequenom Business Overview Table 89. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 91. Sequenom Recent Development Table 92. Ocimum Biosolutions Company Information Table 93. Ocimum Biosolutions Business Overview Table 94. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 96. Ocimum Biosolutions Recent Development Table 97. GE Healthcare Company Information Table 98. GE Healthcare Business Overview Table 99. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 101. GE Healthcare Recent Development Table 102. GenScript Company Information Table 103. GenScript Business Overview Table 104. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 106. GenScript Recent Development Table 107. Douglas Scientific Company Information Table 108. Douglas Scientific Business Overview Table 109. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 111. Douglas Scientific Recent Development Table 112. BGI Company Information Table 113. BGI Business Overview Table 114. BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 116. BGI Recent Development Table 117. Beijing Sunbiotech Company Information Table 118. Beijing Sunbiotech Business Overview Table 119. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 121. Beijing Sunbiotech Recent Development Table 122. HuaGene Biotech Company Information Table 123. HuaGene Biotech Business Overview Table 124. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 126. HuaGene Biotech Recent Development Table 127. Generay Biotech Company Information Table 128. Generay Biotech Business Overview Table 129. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 130. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 131. Generay Biotech Recent Development Table 132. Benegene Company Information Table 133. Benegene Business Overview Table 134. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 135. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 136. Benegene Recent Development Table 137. Shanghai Biochip Company Information Table 138. Shanghai Biochip Business Overview Table 139. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 140. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 141. Shanghai Biochip Recent Development Table 142. GENESKY Company Information Table 143. GENESKY Business Overview Table 144. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 145. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 146. GENESKY Recent Development Table 147. HD Biosciences Company Information Table 148. HD Biosciences Business Overview Table 149. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 150. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 151. HD Biosciences Recent Development Table 152. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026) & (US$ Million) Table 153. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2027-2032) & (US$ Million) Table 154. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026) & (US$ Million) Table 155. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2027-2032) & (US$ Million) Table 156. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026) Table 158. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2027-2032) Table 159. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026) & (US$ Million) Table 160. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2027-2032) & (US$ Million) Table 161. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026) & (US$ Million) Table 162. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2027-2032) & (US$ Million) Table 163. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026) Table 165. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2027-2032) Table 166. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026) & (US$ Million) Table 167. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2027-2032) & (US$ Million) Table 168. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026) & (US$ Million) Table 169. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2027-2032) & (US$ Million) Table 170. Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026) & (US$ Million) Table 171. Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2027-2032) & (US$ Million) Table 172. Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026) & (US$ Million) Table 173. Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2027-2032) & (US$ Million) Table 174. Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026) Table 176. Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2027-2032) Table 177. South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026) & (US$ Million) Table 178. South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2027-2032) & (US$ Million) Table 179. South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026) & (US$ Million) Table 180. South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2027-2032) & (US$ Million) Table 181. South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026) Table 183. South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2027-2032) Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Single Nucleotide Polymorphism (SNP) Genotyping Product Image Figure 2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type: 2025 VS 2032 Figure 4. Transversion Image Figure 5. Transition Image Figure 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2025 VS 2032 Figure 8. Diagnostics Image Figure 9. Animal Image Figure 10. Plant Image Figure 11. Research Image Figure 12. Others Image Figure 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Single Nucleotide Polymorphism (SNP) Genotyping Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2021-2032) Figure 22. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2021-2032) Figure 24. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 25. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2021-2032) Figure 26. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2021-2032) Figure 27. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032) Figure 28. United States Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 29. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 31. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 32. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2021-2032) Figure 33. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2021-2032) Figure 34. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032) Figure 35. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 36. France Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 38. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 39. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 41. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 42. China Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2021-2032) Figure 43. China Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2021-2032) Figure 44. Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 45. Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2021-2032) Figure 46. Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2021-2032) Figure 47. Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032) Figure 48. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 52. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 53. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032) Figure 58. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 63. UAE Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 65. Chile Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Transversion
  • Transition
Applications
  • Diagnostics
  • Animal
  • Plant
  • Research
  • Others
Companies covered
  • Illumina
  • Affymetrix
  • Applied Biosystems
  • Agilent Technologies
  • Beckman Coulter
  • Roche
  • Qiagen
  • Luminex Corporation
  • Enzo Life Sciences
  • Bio-rad
  • Sequenom
  • Ocimum Biosolutions
  • GE Healthcare
  • GenScript
  • Douglas Scientific
  • BGI
  • Beijing Sunbiotech
  • HuaGene Biotech
  • Generay Biotech
  • Benegene
  • Shanghai Biochip
  • GENESKY
  • HD Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Transversion
  5. 1.2.3 Transition
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Diagnostics
  9. 1.3.3 Animal
  10. 1.3.4 Plant
  11. 1.3.5 Research
  12. 1.3.6 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Single Nucleotide Polymorphism (SNP) Genotyping Growth Trends by Region
  15. 1.5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2021-2026)
  17. 1.5.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Dynamics
  1. 2.1 Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends
  2. 2.2 Single Nucleotide Polymorphism (SNP) Genotyping Industry Drivers
  3. 2.3 Single Nucleotide Polymorphism (SNP) Genotyping Industry Opportunities and Challenges
  4. 2.4 Single Nucleotide Polymorphism (SNP) Genotyping Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Company (2021-2026)
  2. 3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Key Company Head office and Area Served
  4. 3.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Company, Product Type & Application
  5. 3.5 Global Single Nucleotide Polymorphism (SNP) Genotyping Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Single Nucleotide Polymorphism (SNP) Genotyping Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Single Nucleotide Polymorphism (SNP) Genotyping Tier 1, Tier 2, and Tier 3
4 Single Nucleotide Polymorphism (SNP) Genotyping Market by Type
  1. 4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2032)
  3. 4.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Type (2021-2032)
5 Single Nucleotide Polymorphism (SNP) Genotyping Market by Application
  1. 5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2032)
  3. 5.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Illumina
  2. 6.1.1 Illumina Company Information
  3. 6.1.2 Illumina Business Overview
  4. 6.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  6. 6.1.5 Illumina Recent Developments
  7. 6.2 Affymetrix
  8. 6.2.1 Affymetrix Company Information
  9. 6.2.2 Affymetrix Business Overview
  10. 6.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  12. 6.2.5 Affymetrix Recent Developments
  13. 6.3 Applied Biosystems
  14. 6.3.1 Applied Biosystems Company Information
  15. 6.3.2 Applied Biosystems Business Overview
  16. 6.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  18. 6.3.5 Applied Biosystems Recent Developments
  19. 6.4 Agilent Technologies
  20. 6.4.1 Agilent Technologies Company Information
  21. 6.4.2 Agilent Technologies Business Overview
  22. 6.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  24. 6.4.5 Agilent Technologies Recent Developments
  25. 6.5 Beckman Coulter
  26. 6.5.1 Beckman Coulter Company Information
  27. 6.5.2 Beckman Coulter Business Overview
  28. 6.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  30. 6.5.5 Beckman Coulter Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Qiagen
  38. 6.7.1 Qiagen Company Information
  39. 6.7.2 Qiagen Business Overview
  40. 6.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  42. 6.7.5 Qiagen Recent Developments
  43. 6.8 Luminex Corporation
  44. 6.8.1 Luminex Corporation Company Information
  45. 6.8.2 Luminex Corporation Business Overview
  46. 6.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  48. 6.8.5 Luminex Corporation Recent Developments
  49. 6.9 Enzo Life Sciences
  50. 6.9.1 Enzo Life Sciences Company Information
  51. 6.9.2 Enzo Life Sciences Business Overview
  52. 6.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  54. 6.9.5 Enzo Life Sciences Recent Developments
  55. 6.10 Bio-rad
  56. 6.10.1 Bio-rad Company Information
  57. 6.10.2 Bio-rad Business Overview
  58. 6.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  60. 6.10.5 Bio-rad Recent Developments
  61. 6.11 Sequenom
  62. 6.11.1 Sequenom Company Information
  63. 6.11.2 Sequenom Business Overview
  64. 6.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  66. 6.11.5 Sequenom Recent Developments
  67. 6.12 Ocimum Biosolutions
  68. 6.12.1 Ocimum Biosolutions Company Information
  69. 6.12.2 Ocimum Biosolutions Business Overview
  70. 6.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  72. 6.12.5 Ocimum Biosolutions Recent Developments
  73. 6.13 GE Healthcare
  74. 6.13.1 GE Healthcare Company Information
  75. 6.13.2 GE Healthcare Business Overview
  76. 6.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  78. 6.13.5 GE Healthcare Recent Developments
  79. 6.14 GenScript
  80. 6.14.1 GenScript Company Information
  81. 6.14.2 GenScript Business Overview
  82. 6.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  84. 6.14.5 GenScript Recent Developments
  85. 6.15 Douglas Scientific
  86. 6.15.1 Douglas Scientific Company Information
  87. 6.15.2 Douglas Scientific Business Overview
  88. 6.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  90. 6.15.5 Douglas Scientific Recent Developments
  91. 6.16 BGI
  92. 6.16.1 BGI Company Information
  93. 6.16.2 BGI Business Overview
  94. 6.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  96. 6.16.5 BGI Recent Developments
  97. 6.17 Beijing Sunbiotech
  98. 6.17.1 Beijing Sunbiotech Company Information
  99. 6.17.2 Beijing Sunbiotech Business Overview
  100. 6.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  102. 6.17.5 Beijing Sunbiotech Recent Developments
  103. 6.18 HuaGene Biotech
  104. 6.18.1 HuaGene Biotech Company Information
  105. 6.18.2 HuaGene Biotech Business Overview
  106. 6.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  108. 6.18.5 HuaGene Biotech Recent Developments
  109. 6.19 Generay Biotech
  110. 6.19.1 Generay Biotech Company Information
  111. 6.19.2 Generay Biotech Business Overview
  112. 6.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  114. 6.19.5 Generay Biotech Recent Developments
  115. 6.20 Benegene
  116. 6.20.1 Benegene Company Information
  117. 6.20.2 Benegene Business Overview
  118. 6.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  120. 6.20.5 Benegene Recent Developments
  121. 6.21 Shanghai Biochip
  122. 6.21.1 Shanghai Biochip Company Information
  123. 6.21.2 Shanghai Biochip Business Overview
  124. 6.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  126. 6.21.5 Shanghai Biochip Recent Developments
  127. 6.22 GENESKY
  128. 6.22.1 GENESKY Company Information
  129. 6.22.2 GENESKY Business Overview
  130. 6.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  132. 6.22.5 GENESKY Recent Developments
  133. 6.23 HD Biosciences
  134. 6.23.1 HD Biosciences Company Information
  135. 6.23.2 HD Biosciences Business Overview
  136. 6.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  138. 6.23.5 HD Biosciences Recent Developments
7 North America
  1. 7.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032)
  2. 7.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
  3. 7.2.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026)
  4. 7.2.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2027-2032)
  5. 7.2.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2021-2032)
  6. 7.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
  7. 7.3.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026)
  8. 7.3.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2027-2032)
  9. 7.3.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2021-2032)
  10. 7.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
  11. 7.4.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026)
  13. 7.4.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2027-2032)
  14. 7.4.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032)
  2. 8.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
  3. 8.2.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026)
  4. 8.2.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2027-2032)
  5. 8.2.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2021-2032)
  6. 8.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
  7. 8.3.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026)
  8. 8.3.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2027-2032)
  9. 8.3.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2021-2032)
  10. 8.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
  11. 8.4.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026)
  13. 8.4.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2027-2032)
  14. 8.4.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032)
  2. 9.2 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
  3. 9.2.1 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026)
  4. 9.2.2 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2027-2032)
  5. 9.2.3 China Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2021-2032)
  6. 9.3 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
  7. 9.3.1 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026)
  8. 9.3.2 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2027-2032)
  9. 9.3.3 China Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032)
  2. 10.2 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
  3. 10.2.1 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026)
  4. 10.2.2 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2027-2032)
  5. 10.2.3 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2021-2032)
  6. 10.3 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
  7. 10.3.1 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026)
  8. 10.3.2 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2027-2032)
  9. 10.3.3 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2021-2032)
  10. 10.4 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
  11. 10.4.1 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026)
  13. 10.4.3 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2027-2032)
  14. 10.4.4 Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst